Global Large Molecule Injectable Drugs Market Research Report 2023

Report ID: 1891902 | Published Date: Oct 2024 | No. of Page: 94 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Large Molecule Injectable Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Intravenous Injection
        1.2.3 Muscle Injection
        1.2.4 Subcutaneous Injection
    1.3 Market by Application
        1.3.1 Global Large Molecule Injectable Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Large Molecule Injectable Drugs Market Perspective (2017-2028)
    2.2 Large Molecule Injectable Drugs Growth Trends by Region
        2.2.1 Large Molecule Injectable Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Large Molecule Injectable Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Large Molecule Injectable Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Large Molecule Injectable Drugs Market Dynamics
        2.3.1 Large Molecule Injectable Drugs Industry Trends
        2.3.2 Large Molecule Injectable Drugs Market Drivers
        2.3.3 Large Molecule Injectable Drugs Market Challenges
        2.3.4 Large Molecule Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Large Molecule Injectable Drugs Players by Revenue
        3.1.1 Global Top Large Molecule Injectable Drugs Players by Revenue (2017-2022)
        3.1.2 Global Large Molecule Injectable Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Large Molecule Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Large Molecule Injectable Drugs Revenue
    3.4 Global Large Molecule Injectable Drugs Market Concentration Ratio
        3.4.1 Global Large Molecule Injectable Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Large Molecule Injectable Drugs Revenue in 2021
    3.5 Large Molecule Injectable Drugs Key Players Head office and Area Served
    3.6 Key Players Large Molecule Injectable Drugs Product Solution and Service
    3.7 Date of Enter into Large Molecule Injectable Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Large Molecule Injectable Drugs Breakdown Data by Type
    4.1 Global Large Molecule Injectable Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Large Molecule Injectable Drugs Forecasted Market Size by Type (2023-2028)
5 Large Molecule Injectable Drugs Breakdown Data by Application
    5.1 Global Large Molecule Injectable Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Large Molecule Injectable Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Large Molecule Injectable Drugs Market Size (2017-2028)
    6.2 North America Large Molecule Injectable Drugs Market Size by Country (2017-2022)
    6.3 North America Large Molecule Injectable Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Large Molecule Injectable Drugs Market Size (2017-2028)
    7.2 Europe Large Molecule Injectable Drugs Market Size by Country (2017-2022)
    7.3 Europe Large Molecule Injectable Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Large Molecule Injectable Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Large Molecule Injectable Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Large Molecule Injectable Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Large Molecule Injectable Drugs Market Size (2017-2028)
    9.2 Latin America Large Molecule Injectable Drugs Market Size by Country (2017-2022)
    9.3 Latin America Large Molecule Injectable Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Large Molecule Injectable Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Biogen
        11.1.1 Biogen Company Detail
        11.1.2 Biogen Business Overview
        11.1.3 Biogen Large Molecule Injectable Drugs Introduction
        11.1.4 Biogen Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.1.5 Biogen Recent Development
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Detail
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Large Molecule Injectable Drugs Introduction
        11.2.4 AstraZeneca Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.2.5 AstraZeneca Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Large Molecule Injectable Drugs Introduction
        11.3.4 Roche Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Sun Pharmaceutical
        11.4.1 Sun Pharmaceutical Company Detail
        11.4.2 Sun Pharmaceutical Business Overview
        11.4.3 Sun Pharmaceutical Large Molecule Injectable Drugs Introduction
        11.4.4 Sun Pharmaceutical Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.4.5 Sun Pharmaceutical Recent Development
    11.5 Medtronic
        11.5.1 Medtronic Company Detail
        11.5.2 Medtronic Business Overview
        11.5.3 Medtronic Large Molecule Injectable Drugs Introduction
        11.5.4 Medtronic Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.5.5 Medtronic Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Detail
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Large Molecule Injectable Drugs Introduction
        11.6.4 Novartis Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.6.5 Novartis Recent Development
    11.7 ​​Baxter
        11.7.1 ​​Baxter Company Detail
        11.7.2 ​​Baxter Business Overview
        11.7.3 ​​Baxter Large Molecule Injectable Drugs Introduction
        11.7.4 ​​Baxter Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.7.5 ​​Baxter Recent Development
    11.8 Amgen
        11.8.1 Amgen Company Detail
        11.8.2 Amgen Business Overview
        11.8.3 Amgen Large Molecule Injectable Drugs Introduction
        11.8.4 Amgen Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.8.5 Amgen Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Detail
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Large Molecule Injectable Drugs Introduction
        11.9.4 Pfizer Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.9.5 Pfizer Recent Development
    11.10 Johnson & Johnson
        11.10.1 Johnson & Johnson Company Detail
        11.10.2 Johnson & Johnson Business Overview
        11.10.3 Johnson & Johnson Large Molecule Injectable Drugs Introduction
        11.10.4 Johnson & Johnson Revenue in Large Molecule Injectable Drugs Business (2017-2022)
        11.10.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Large Molecule Injectable Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Intravenous Injection
    Table 3. Key Players of Muscle Injection
    Table 4. Key Players of Subcutaneous Injection
    Table 5. Global Large Molecule Injectable Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Large Molecule Injectable Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Large Molecule Injectable Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Large Molecule Injectable Drugs Market Share by Region (2017-2022)
    Table 9. Global Large Molecule Injectable Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Large Molecule Injectable Drugs Market Share by Region (2023-2028)
    Table 11. Large Molecule Injectable Drugs Market Trends
    Table 12. Large Molecule Injectable Drugs Market Drivers
    Table 13. Large Molecule Injectable Drugs Market Challenges
    Table 14. Large Molecule Injectable Drugs Market Restraints
    Table 15. Global Large Molecule Injectable Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Large Molecule Injectable Drugs Market Share by Players (2017-2022)
    Table 17. Global Top Large Molecule Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Large Molecule Injectable Drugs as of 2021)
    Table 18. Ranking of Global Top Large Molecule Injectable Drugs Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Large Molecule Injectable Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Large Molecule Injectable Drugs Product Solution and Service
    Table 22. Date of Enter into Large Molecule Injectable Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Large Molecule Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Large Molecule Injectable Drugs Revenue Market Share by Type (2017-2022)
    Table 26. Global Large Molecule Injectable Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Large Molecule Injectable Drugs Revenue Market Share by Type (2023-2028)
    Table 28. Global Large Molecule Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Large Molecule Injectable Drugs Revenue Market Share by Application (2017-2022)
    Table 30. Global Large Molecule Injectable Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Large Molecule Injectable Drugs Revenue Market Share by Application (2023-2028)
    Table 32. North America Large Molecule Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Large Molecule Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Large Molecule Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Large Molecule Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Large Molecule Injectable Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Large Molecule Injectable Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Large Molecule Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Large Molecule Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Biogen Company Detail
    Table 43. Biogen Business Overview
    Table 44. Biogen Large Molecule Injectable Drugs Product
    Table 45. Biogen Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 46. Biogen Recent Development
    Table 47. AstraZeneca Company Detail
    Table 48. AstraZeneca Business Overview
    Table 49. AstraZeneca Large Molecule Injectable Drugs Product
    Table 50. AstraZeneca Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 51. AstraZeneca Recent Development
    Table 52. Roche Company Detail
    Table 53. Roche Business Overview
    Table 54. Roche Large Molecule Injectable Drugs Product
    Table 55. Roche Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 56. Roche Recent Development
    Table 57. Sun Pharmaceutical Company Detail
    Table 58. Sun Pharmaceutical Business Overview
    Table 59. Sun Pharmaceutical Large Molecule Injectable Drugs Product
    Table 60. Sun Pharmaceutical Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 61. Sun Pharmaceutical Recent Development
    Table 62. Medtronic Company Detail
    Table 63. Medtronic Business Overview
    Table 64. Medtronic Large Molecule Injectable Drugs Product
    Table 65. Medtronic Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 66. Medtronic Recent Development
    Table 67. Novartis Company Detail
    Table 68. Novartis Business Overview
    Table 69. Novartis Large Molecule Injectable Drugs Product
    Table 70. Novartis Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 71. Novartis Recent Development
    Table 72. ​​Baxter Company Detail
    Table 73. ​​Baxter Business Overview
    Table 74. ​​Baxter Large Molecule Injectable Drugs Product
    Table 75. ​​Baxter Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 76. ​​Baxter Recent Development
    Table 77. Amgen Company Detail
    Table 78. Amgen Business Overview
    Table 79. Amgen Large Molecule Injectable Drugs Product
    Table 80. Amgen Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 81. Amgen Recent Development
    Table 82. Pfizer Company Detail
    Table 83. Pfizer Business Overview
    Table 84. Pfizer Large Molecule Injectable Drugs Product
    Table 85. Pfizer Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 86. Pfizer Recent Development
    Table 87. Johnson & Johnson Company Detail
    Table 88. Johnson & Johnson Business Overview
    Table 89. Johnson & Johnson Large Molecule Injectable Drugs Product
    Table 90. Johnson & Johnson Revenue in Large Molecule Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 91. Johnson & Johnson Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Large Molecule Injectable Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Intravenous Injection Features
    Figure 3. Muscle Injection Features
    Figure 4. Subcutaneous Injection Features
    Figure 5. Global Large Molecule Injectable Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospital Pharmacies Case Studies
    Figure 7. Retail Pharmacies Case Studies
    Figure 8. Online Pharmacies Case Studies
    Figure 9. Large Molecule Injectable Drugs Report Years Considered
    Figure 10. Global Large Molecule Injectable Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Large Molecule Injectable Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Large Molecule Injectable Drugs Market Share by Region: 2021 VS 2028
    Figure 13. Global Large Molecule Injectable Drugs Market Share by Players in 2021
    Figure 14. Global Top Large Molecule Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Large Molecule Injectable Drugs as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Large Molecule Injectable Drugs Revenue in 2021
    Figure 16. North America Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Large Molecule Injectable Drugs Market Share by Country (2017-2028)
    Figure 18. United States Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Large Molecule Injectable Drugs Market Share by Country (2017-2028)
    Figure 22. Germany Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Large Molecule Injectable Drugs Market Share by Region (2017-2028)
    Figure 30. China Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Large Molecule Injectable Drugs Market Share by Country (2017-2028)
    Figure 38. Mexico Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Large Molecule Injectable Drugs Market Share by Country (2017-2028)
    Figure 42. Turkey Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Large Molecule Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Biogen Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 45. AstraZeneca Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 46. Roche Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 47. Sun Pharmaceutical Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 48. Medtronic Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 50. ​​Baxter Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 51. Amgen Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 52. Pfizer Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 53. Johnson & Johnson Revenue Growth Rate in Large Molecule Injectable Drugs Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biogen
AstraZeneca
Roche
Sun Pharmaceutical
Medtronic
Novartis
​​Baxter
Amgen
Pfizer
Johnson & Johnson
Frequently Asked Questions
Large Molecule Injectable Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Large Molecule Injectable Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Large Molecule Injectable Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Syphilis Diagnosis

Syphilis Diagnosis market is segmented by players, region (country), by Type and by Application.  ... Read More